By Editorial Staff
June 30, 2026
For millions of individuals worldwide, the word "cancer" is synonymous with a battle to be fought. But for a growing demographic known as "previvors"—people who carry a genetic predisposition to cancer but have not yet received a diagnosis—the battle is fought in the quiet, often isolating space of anticipation.
Laura Schneebaum, a therapist specializing in hereditary cancer, recently highlighted a glaring oversight in the current medical and psychological landscape: the mental health needs of those living in the shadow of high-risk genetic mutations. Despite the rapid advancement of genetic testing and preventive medicine, the psychological toll of knowing one’s biological future remains an under-discussed crisis.
Main Facts: Defining the Previvor Experience
A "previvor" is defined as a person who is a survivor of a predisposition to cancer. This includes individuals who carry mutations in genes such as BRCA1, BRCA2, PALB2, or those who have hereditary syndromes like Lynch syndrome. Unlike patients currently undergoing chemotherapy or radiation, previvors are often navigating a "liminal space"—a state of being healthy yet perpetually at risk.
The primary mental health challenges identified by clinical experts include:
- Chronic Anticipatory Anxiety: The constant fear that "today is the day" a tumor might be discovered.
- Survivor’s Guilt: Feeling conflicted about being "healthy" while family members may have succumbed to the disease.
- Medical Trauma: The stress of frequent, invasive screenings, prophylactic surgeries (such as mastectomies or oophorectomies), and the weight of genetic counseling.
- Isolation: A sense that friends and family—who do not share the genetic burden—cannot truly comprehend the weight of living with a high-risk status.
Schneebaum notes that while the medical community has become excellent at identifying genetic risks, it has largely failed to provide the necessary psychological infrastructure to support those carrying that knowledge.
Chronology: The Evolution of Genetic Awareness
The conversation around previvors has evolved significantly over the last two decades:
- 2000s – The Genetic Awakening: As widespread BRCA testing became commercially available, the focus was almost entirely on mortality rates and surgical intervention. Psychological screening was secondary to physical risk reduction.
- 2013 – The "Angelina Jolie Effect": Following the actress’s public disclosure of her BRCA mutation and subsequent preventative surgeries, the term "previvor" entered the public lexicon. This brought visibility but also intensified the pressure on those who were unsure of their own path.
- 2020-2025 – The Rise of Precision Medicine: Advances in genetic sequencing allowed for more nuanced risk assessments, leading to an increase in the number of people identifying as high-risk.
- 2026 – The Mental Health Pivot: Professionals like Schneebaum are now leading a movement to shift the focus from solely "risk management" to "mental health management," recognizing that the brain is as much a patient as the body.
Supporting Data: The Hidden Toll
Data from oncology-focused mental health studies suggests that individuals with high-risk genetic mutations experience higher rates of generalized anxiety disorder (GAD) and depression compared to the general population.
- Screening Fatigue: Studies indicate that roughly 40% of high-risk individuals experience "scanxiety"—intense physiological stress leading up to breast MRIs, mammograms, or colonoscopies.
- Decision-Making Distress: Approximately 65% of previvors report experiencing long-term emotional distress regarding the timing and necessity of prophylactic surgeries.
- The Gap in Care: Research published in the Journal of Psychosocial Oncology suggests that fewer than 15% of genetic counseling centers provide formalized, long-term psychological follow-up for patients who test positive for high-risk mutations.
Official Responses and Clinical Perspectives
The medical community is beginning to acknowledge the gap, though progress is slow. Organizations like Sharsheret have stepped in to fill the void, providing specialized support systems for those navigating the "Waiting Room" of life.
"As a therapist, it baffles me that so few mental health professionals are talking about the unique challenges previvors face," says Schneebaum. "Many aspects of being a previvor are unseen by others and can leave them feeling anxious, alone, or overwhelmed."
Medical associations are now being urged to integrate mental health screenings directly into the genetic counseling process. The goal is to move toward a "whole-patient" model, where a patient is not merely given a probability score but is also provided with a mental health roadmap to help process that information.
Implications: The Road Ahead
The implications of ignoring the mental health of previvors are significant. Left unaddressed, chronic stress can lead to physical burnout, avoidance of necessary screenings, and a degradation in the overall quality of life.
Developing Personal Coping Strategies
While there is no one-size-fits-all approach, experts suggest four pillars of management for those living with high-risk status:
- Normalization of the "Waiting Room": Recognizing that the anxiety of waiting for results is a valid, documented medical experience. It is not a sign of weakness; it is a rational response to a high-stakes environment.
- Community Integration: Engaging with groups like Sharsheret that provide peer support. Talking to others who understand the specific nuance of "pre-cancerous" anxiety is essential for mitigating the feeling of being "the only one."
- Active Management vs. Passive Worry: Transforming the energy of fear into a structured action plan. This includes scheduling screenings, maintaining clear communication with medical teams, and setting boundaries on how much time is spent researching genetic data.
- Psychological Professionalism: Seeking therapy from professionals who are specifically trained in hereditary cancer syndromes. General anxiety therapy is often insufficient for the unique "existential threat" experienced by previvors.
Conclusion
The era of focusing solely on the biological data of cancer risk is coming to a close. The next frontier in oncology and genetic health is the emotional wellbeing of those who live with the knowledge of what might happen.
By prioritizing mental health, the medical community can ensure that previvors are not just surviving in the shadow of their genes, but are thriving in spite of them. Organizations like Sharsheret, supported by partners like AstraZeneca and Merck, continue to provide the resources necessary for this journey, offering a lifeline to those currently navigating the fear of the unknown.
For those currently living with a genetic predisposition, the message is clear: You are not alone, and your mental health is as critical as your physical health. Seeking support is not a concession—it is a vital part of your prevention strategy.
For those seeking resources, support, or a community of peers, visit Sharsheret’s Waiting Room for more information on managing the road ahead.
About the Author
